Insiders Moderna, Inc.

Equities

MRNA

US60770K1079

Real-time Estimate Cboe BZX Other stock markets 09:53:02 2024-04-30 am EDT			5-day change	1st Jan Change
111.1 ^USD	-0.46%		+2.29%	+10.97%

07:41am	Wall Street: buoyed by Tesla, confident ahead of FOMC meeting	CF
Apr. 29	Wall Street: buoyed by Tesla, confident ahead of FOMC meeting	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China's drugmakers can't sell mRNA shots but haven't quit yet	Apr. 19	RE
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Moderna CEO: 'Excited' About Future Following 4Q Revenue	Feb. 22	MT
Moderna Insider Sold Shares Worth $936,981, According to a Recent SEC Filing	Feb. 16	MT
Moderna Insider Sold Shares Worth $2,342,098, According to a Recent SEC Filing	Feb. 16	MT
Lonza chairman to step down, drugmaker confirms targets, shares soar	Jan. 26	RE
Moderna Insider Sold Shares Worth $1,558,500, According to a Recent SEC Filing	Jan. 17	MT
Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector	Jan. 16	MT
Top Stories at Midday: Boeing Declines After FAA Grounding; Twilio Names New CEO; Johnson & Johnson May Pay $700 Million Talc Probe Settlement; Moderna Rises on $6.7 Billion COVID-19 Vaccine Sales	Jan. 08	MT
Moderna Insider Sold Shares Worth $4,500,450, According to a Recent SEC Filing	Dec. 28	MT
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence	Dec. 14	MT
Moderna CEO Stephane Bancel to Assume Responsibility for Sales, Marketing in 2024 Amid Preparations for Product Launches	Dec. 12	MT
Moderna chief commercial officer steps down	Dec. 12	RE
Moderna Announces Changes to Commercial Organization	Dec. 12	CI
Moderna Chairman Afeyan on Industry Outlook, Strategy, AI	Nov. 09	MT
Arbutus Biopharma Posts Q3 Net Loss, Lower Revenue; CEO to Retire, 24% Research Staff Cut	Nov. 07	MT
Stéphane Bancel, CEO of Moderna: sales down, restructuring underway, acquisitions to come	Nov. 02	MT
Lonza cuts 2024 margin target again after CEO departure	23-10-17	RE
Moderna Insider Sold Shares Worth $292,953, According to a Recent SEC Filing	23-10-10	MT
Moderna Insider Sold Shares Worth $1,540,845, According to a Recent SEC Filing	23-10-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST